Corvium’s mission is to use data to make the world a safer place to eat. Our food risk intelligence platform continuously aggregates and analyzes risk and quality data generated during food production and distribution. Our solutions help food producers and processors prevent pathogenic contamination, comply with federal regulations and internal safety and quality programs, reduce the food safety risks and costs, and reduce food waste.
Corvium is a privately held company, launched in 2018 with financial backing from private investors. The products and technology developed by Corvium are based on original developments that occurred in 2010 – 2017 under the former company brand name: Sample6. In 2017, the Sample6 brand and a set of technology and products known as DETECT(TM) were acquired by a third party.
Sample6’s core technology was originally developed and conceived in Dr. James Collins’ lab at Boston University. Tim Lu, Michael Koeris and Tanguy Chau, who were then Ph.D. students at BU and MIT, first founded the Company in March 2009 under the name Novophage Therapeutics, Inc. Through a number of successes in business plan competitions, Lu, Koeris and Chau jointly developed and explored a variety of applications for the technology, including using bacteriophages as a therapeutic treatment for bacterial infections. From these early seeds eventually grew what is now Sample6. The Sample6 brand is now wholly owned by Phage Diagnostics, Inc.